Importantly, the selective uptake of [68Ga]Ga-DOTAGA-Glu(FAPi)2 in FAP-expressing tissues, rather than non-target tissues, highlights its precision in targeting and imaging FAP-expressing tumors, making it a promising tool for the management of FAP-positive cancers. Here, FAP is linked to cancer.